nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A pathway to developing and testing quality measures aimed at improving adult vaccination rates in the United States
|
Shen, Angela K. |
|
2019 |
37 |
10 |
p. 1277-1283 |
artikel |
2 |
A population-based study of maternal and infant factors influencing influenza vaccination among young children born in Colorado from 2008 to 2016
|
Rao, Suchitra |
|
2019 |
37 |
10 |
p. 1293-1298 |
artikel |
3 |
Corrigendum to ‘A report on the status of vaccination in Europe’ [Vaccine 36 (2018) 4979–4992]
|
Sheikh, Shazia |
|
2019 |
37 |
10 |
p. 1374-1376 |
artikel |
4 |
Cross-protective Salmonella vaccine reduces cecal and splenic colonization of multidrug-resistant Salmonella enterica serovar Heidelberg
|
Bearson, Shawn M.D. |
|
2019 |
37 |
10 |
p. 1255-1259 |
artikel |
5 |
Editorial Board/Aims and Scope
|
|
|
2019 |
37 |
10 |
p. IFC |
artikel |
6 |
Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial
|
Borgey, France |
|
2019 |
37 |
10 |
p. 1260-1265 |
artikel |
7 |
Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial
|
Wildes, Tyler J. |
|
2019 |
37 |
10 |
p. 1313-1324 |
artikel |
8 |
Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population
|
Petrie, Joshua G. |
|
2019 |
37 |
10 |
p. 1284-1292 |
artikel |
9 |
Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens
|
Ghorbani, Amir |
|
2019 |
37 |
10 |
p. 1356-1364 |
artikel |
10 |
Multi-antigenic recombinant subunit vaccine against Lawsonia intracellularis: The etiological agent of porcine proliferative enteropathy
|
Montesino, R. |
|
2019 |
37 |
10 |
p. 1340-1349 |
artikel |
11 |
Needle-free delivery of influenza vaccine using the Med-Jet® H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial
|
Shapiro, Janna R. |
|
2019 |
37 |
10 |
p. 1332-1339 |
artikel |
12 |
Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention
|
Dempsey, A.F. |
|
2019 |
37 |
10 |
p. 1307-1312 |
artikel |
13 |
Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland
|
Polkowska, Aleksandra |
|
2019 |
37 |
10 |
p. 1365-1373 |
artikel |
14 |
Serum antibody immunoreactivity and safety of native porcine and recombinant zona pellucida vaccines formulated with a non-Freund’s adjuvant in horses
|
Nolan, Margaret B. |
|
2019 |
37 |
10 |
p. 1299-1306 |
artikel |
15 |
The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax®23) in a healthy adult population and patients diagnosed with primary immunodeficiencies
|
Parker, Antony R |
|
2019 |
37 |
10 |
p. 1350-1355 |
artikel |
16 |
Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule
|
Xu, Stanley |
|
2019 |
37 |
10 |
p. 1325-1331 |
artikel |
17 |
Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes
|
Roy, S. |
|
2019 |
37 |
10 |
p. 1266-1276 |
artikel |